Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome

Standard

Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome. / Emrich, Fabian C; Okamura, Homare; Dalal, Alex R; Penov, Kiril; Merk, Denis R; Raaz, Uwe; Hennigs, Jan K; Chin, Jocelyn T; Miller, Miquell O; Pedroza, Albert J; Craig, Juliana K; Koyano, Tiffany K; Blankenberg, Francis G; Connolly, Andrew J; Mohr, Friedrich W; Alvira, Cristina M; Rabinovitch, Marlene; Fischbein, Michael P.

In: ARTERIOSCL THROM VAS, Vol. 35, No. 1, 01.2015, p. 146-54.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Emrich, FC, Okamura, H, Dalal, AR, Penov, K, Merk, DR, Raaz, U, Hennigs, JK, Chin, JT, Miller, MO, Pedroza, AJ, Craig, JK, Koyano, TK, Blankenberg, FG, Connolly, AJ, Mohr, FW, Alvira, CM, Rabinovitch, M & Fischbein, MP 2015, 'Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome', ARTERIOSCL THROM VAS, vol. 35, no. 1, pp. 146-54. https://doi.org/10.1161/ATVBAHA.114.304364

APA

Emrich, F. C., Okamura, H., Dalal, A. R., Penov, K., Merk, D. R., Raaz, U., Hennigs, J. K., Chin, J. T., Miller, M. O., Pedroza, A. J., Craig, J. K., Koyano, T. K., Blankenberg, F. G., Connolly, A. J., Mohr, F. W., Alvira, C. M., Rabinovitch, M., & Fischbein, M. P. (2015). Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome. ARTERIOSCL THROM VAS, 35(1), 146-54. https://doi.org/10.1161/ATVBAHA.114.304364

Vancouver

Bibtex

@article{9783417e8a7846a59857b604eb489ec8,
title = "Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome",
abstract = "OBJECTIVE: Rupture and dissection of aortic root aneurysms remain the leading causes of death in patients with the Marfan syndrome, a hereditary connective tissue disorder that affects 1 in 5000 individuals worldwide. In the present study, we use a Marfan mouse model (Fbn1(C1039G/+)) to investigate the biological importance of apoptosis during aneurysm development in Marfan syndrome.APPROACH AND RESULTS: Using in vivo single-photon emission computed tomographic-imaging and ex vivo autoradiography for Tc99m-annexin, we discovered increased apoptosis in the Fbn1(C1039G/+) ascending aorta during early aneurysm development peaking at 4 weeks. Immunofluorescence colocalization studies identified smooth muscle cells (SMCs) as the apoptotic cell population. As biological proof of concept that early aortic wall apoptosis plays a role in aneurysm development in Marfan syndrome, Fbn1(C1039G/+) mice were treated daily from 2 to 6 weeks with either (1) a pan-caspase inhibitor, Q-VD-OPh (20 mg/kg), or (2) vehicle control intraperitoneally. Q-VD-OPh treatment led to a significant reduction in aneurysm size and decreased extracellular matrix degradation in the aortic wall compared with control mice. In vitro studies using Fbn1(C1039G/+) ascending SMCs showed that apoptotic SMCs have increased elastolytic potential compared with viable cells, mostly because of caspase activity. Moreover, in vitro (1) cell membrane isolation, (2) immunofluorescence staining, and (3) scanning electron microscopy studies illustrate that caspases are expressed on the exterior cell surface of apoptotic SMCs.CONCLUSIONS: Caspase inhibition attenuates aneurysm development in an Fbn1(C1039G/+) Marfan mouse model. Mechanistically, during apoptosis, caspases are expressed on the cell surface of SMCs and likely contribute to elastin degradation and aneurysm development in Marfan syndrome.",
keywords = "Animals, Aorta, Aortic Aneurysm, Apoptosis, Autoradiography, Caspase Inhibitors, Caspases, Cell Membrane, Cells, Cultured, Disease Models, Animal, Disease Progression, Elastin, Female, Fluorescent Antibody Technique, Male, Marfan Syndrome, Mice, Inbred C57BL, Mice, Mutant Strains, Microfilament Proteins, Microscopy, Electron, Scanning, Muscle, Smooth, Vascular, Mutation, Myocytes, Smooth Muscle, Time Factors, Tomography, Emission-Computed, Single-Photon, Vascular Remodeling",
author = "Emrich, {Fabian C} and Homare Okamura and Dalal, {Alex R} and Kiril Penov and Merk, {Denis R} and Uwe Raaz and Hennigs, {Jan K} and Chin, {Jocelyn T} and Miller, {Miquell O} and Pedroza, {Albert J} and Craig, {Juliana K} and Koyano, {Tiffany K} and Blankenberg, {Francis G} and Connolly, {Andrew J} and Mohr, {Friedrich W} and Alvira, {Cristina M} and Marlene Rabinovitch and Fischbein, {Michael P}",
note = "{\textcopyright} 2014 American Heart Association, Inc.",
year = "2015",
month = jan,
doi = "10.1161/ATVBAHA.114.304364",
language = "English",
volume = "35",
pages = "146--54",
journal = "ARTERIOSCL THROM VAS",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

RIS

TY - JOUR

T1 - Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome

AU - Emrich, Fabian C

AU - Okamura, Homare

AU - Dalal, Alex R

AU - Penov, Kiril

AU - Merk, Denis R

AU - Raaz, Uwe

AU - Hennigs, Jan K

AU - Chin, Jocelyn T

AU - Miller, Miquell O

AU - Pedroza, Albert J

AU - Craig, Juliana K

AU - Koyano, Tiffany K

AU - Blankenberg, Francis G

AU - Connolly, Andrew J

AU - Mohr, Friedrich W

AU - Alvira, Cristina M

AU - Rabinovitch, Marlene

AU - Fischbein, Michael P

N1 - © 2014 American Heart Association, Inc.

PY - 2015/1

Y1 - 2015/1

N2 - OBJECTIVE: Rupture and dissection of aortic root aneurysms remain the leading causes of death in patients with the Marfan syndrome, a hereditary connective tissue disorder that affects 1 in 5000 individuals worldwide. In the present study, we use a Marfan mouse model (Fbn1(C1039G/+)) to investigate the biological importance of apoptosis during aneurysm development in Marfan syndrome.APPROACH AND RESULTS: Using in vivo single-photon emission computed tomographic-imaging and ex vivo autoradiography for Tc99m-annexin, we discovered increased apoptosis in the Fbn1(C1039G/+) ascending aorta during early aneurysm development peaking at 4 weeks. Immunofluorescence colocalization studies identified smooth muscle cells (SMCs) as the apoptotic cell population. As biological proof of concept that early aortic wall apoptosis plays a role in aneurysm development in Marfan syndrome, Fbn1(C1039G/+) mice were treated daily from 2 to 6 weeks with either (1) a pan-caspase inhibitor, Q-VD-OPh (20 mg/kg), or (2) vehicle control intraperitoneally. Q-VD-OPh treatment led to a significant reduction in aneurysm size and decreased extracellular matrix degradation in the aortic wall compared with control mice. In vitro studies using Fbn1(C1039G/+) ascending SMCs showed that apoptotic SMCs have increased elastolytic potential compared with viable cells, mostly because of caspase activity. Moreover, in vitro (1) cell membrane isolation, (2) immunofluorescence staining, and (3) scanning electron microscopy studies illustrate that caspases are expressed on the exterior cell surface of apoptotic SMCs.CONCLUSIONS: Caspase inhibition attenuates aneurysm development in an Fbn1(C1039G/+) Marfan mouse model. Mechanistically, during apoptosis, caspases are expressed on the cell surface of SMCs and likely contribute to elastin degradation and aneurysm development in Marfan syndrome.

AB - OBJECTIVE: Rupture and dissection of aortic root aneurysms remain the leading causes of death in patients with the Marfan syndrome, a hereditary connective tissue disorder that affects 1 in 5000 individuals worldwide. In the present study, we use a Marfan mouse model (Fbn1(C1039G/+)) to investigate the biological importance of apoptosis during aneurysm development in Marfan syndrome.APPROACH AND RESULTS: Using in vivo single-photon emission computed tomographic-imaging and ex vivo autoradiography for Tc99m-annexin, we discovered increased apoptosis in the Fbn1(C1039G/+) ascending aorta during early aneurysm development peaking at 4 weeks. Immunofluorescence colocalization studies identified smooth muscle cells (SMCs) as the apoptotic cell population. As biological proof of concept that early aortic wall apoptosis plays a role in aneurysm development in Marfan syndrome, Fbn1(C1039G/+) mice were treated daily from 2 to 6 weeks with either (1) a pan-caspase inhibitor, Q-VD-OPh (20 mg/kg), or (2) vehicle control intraperitoneally. Q-VD-OPh treatment led to a significant reduction in aneurysm size and decreased extracellular matrix degradation in the aortic wall compared with control mice. In vitro studies using Fbn1(C1039G/+) ascending SMCs showed that apoptotic SMCs have increased elastolytic potential compared with viable cells, mostly because of caspase activity. Moreover, in vitro (1) cell membrane isolation, (2) immunofluorescence staining, and (3) scanning electron microscopy studies illustrate that caspases are expressed on the exterior cell surface of apoptotic SMCs.CONCLUSIONS: Caspase inhibition attenuates aneurysm development in an Fbn1(C1039G/+) Marfan mouse model. Mechanistically, during apoptosis, caspases are expressed on the cell surface of SMCs and likely contribute to elastin degradation and aneurysm development in Marfan syndrome.

KW - Animals

KW - Aorta

KW - Aortic Aneurysm

KW - Apoptosis

KW - Autoradiography

KW - Caspase Inhibitors

KW - Caspases

KW - Cell Membrane

KW - Cells, Cultured

KW - Disease Models, Animal

KW - Disease Progression

KW - Elastin

KW - Female

KW - Fluorescent Antibody Technique

KW - Male

KW - Marfan Syndrome

KW - Mice, Inbred C57BL

KW - Mice, Mutant Strains

KW - Microfilament Proteins

KW - Microscopy, Electron, Scanning

KW - Muscle, Smooth, Vascular

KW - Mutation

KW - Myocytes, Smooth Muscle

KW - Time Factors

KW - Tomography, Emission-Computed, Single-Photon

KW - Vascular Remodeling

U2 - 10.1161/ATVBAHA.114.304364

DO - 10.1161/ATVBAHA.114.304364

M3 - SCORING: Journal article

C2 - 25359856

VL - 35

SP - 146

EP - 154

JO - ARTERIOSCL THROM VAS

JF - ARTERIOSCL THROM VAS

SN - 1079-5642

IS - 1

ER -